RecruitingPhase 2NCT06429501

Local Anesthesia for Facial Fractures

The Impact of Perioperative Nerve Block on Opioid Use After Craniomaxillofacial Trauma Surgery: A Randomized Controlled Trial


Sponsor

Washington University School of Medicine

Enrollment

70 participants

Start Date

Apr 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The study is a double-blind randomized, placebo controlled trial examining the impact of perioperative bupivacaine nerve block on PACU recovery metrics. Patients with operative facial fractures are randomized to receive either bupivacaine or saline injections prior to the anesthesia emergence.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Adults age 18 and over
  • Isolated facial fracture to the mandible and/or midface undergoing surgical repair
  • No allergy to local anesthetic
  • Ability to read, write, and understand English

Exclusion Criteria4

  • Patients under the age of 18
  • Isolated nasal bone fracture
  • Polytrauma (I.e. injury pattern resulting in hospital admission for multiple bony fractures outside of the face)
  • Allergy to local anesthetic

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBupivacaine/Epinephrine

injection

DRUGSaline

injection


Locations(1)

Washington University

St Louis, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06429501


Related Trials